Navigation Links
Fosamax Lawsuits Update: Rottenstein Law Group LLP Comments on Reported $28 Million Merck ‘Jaw Death’ Settlement
Date:12/10/2013

(PRWEB) December 10, 2013

Drugmaker Merck announced on Dec. 9 that it has agreed to pay about $28 million to settle Fosamax lawsuits stemming from claims that the osteoporosis drug caused patients’ jaws to deteriorate, or even “die,” according to Reuters. The Rottenstein Law Group LLP notes that the settlement involves more than 1,140 lawsuits in federal and state courts.

In order for the settlement to succeed, it requires 100 percent participation from the plaintiffs in the lawsuits, according to a Dec. 9 Reuters story.* The deadline to signal intent to file is Jan. 13. (In Re Fosamax Products Liability Litigation; 06-md-01789, U.S. District Court, Southern District of New York.)

“The decision to settle is not one to approach lightly,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP. “Plaintiffs in these Fosamax lawsuits need to consult with their qualified counsel to adequately and accurately assess their needs, and to determine if a settlement is the preferred outcome.”

The settlement applies only to those cases involving the deterioration or death of the jaw, according to Reuters. There are more than 4,000 Fosamax lawsuits involving femur fracture claims in state and federal courts, and those claimants are not eligible for a settlement, Reuters said.

The Rottenstein Law Group LLP encourages people to download a free informational brochure to learn more about the drug’s side effects and how to file a lawsuit.

*reuters.com/article/2013/12/09/us-merck-fosamax-idUSBRE9B811S20131209

About THE ROTTENSTEIN LAW GROUP LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

Contact:
The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com
plus.google.com/106070664376281033016

Read the full story at http://www.prweb.com/releases/fosamax-settlement/fosamax-lawsuits/prweb11409526.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. US Drug Watchdog Now Offers To Help Women Who Used TheOsteoporosis Drug Called Fosamax And Then Had A Unexplainable Femur Fracture Get To The Best Attorneys Or Law Firms
2. US Drug Watchdog Now Offers to Help All Woman Who Used Fosamax For Osteoporosis and Then Had an Unexplained a Femur Break Get to the Best Attorneys
3. The Law Firm of d'Oliveira & Associates Now Offers a No Win - No Fee Promise in Fosamax Cases
4. New Lawsuit Alleges Fosamax Increases Risk of Injury: Now, AttorneyOne Can Provide Advice
5. Fosamax Lawsuit Update: Bernstein Liebhard LLP Notes Nearly 2,600 Claims Alleging Fosamax Femur Fractures, Other Side Effects, Pending in New Jersey State Litigation
6. Fosamax Lawsuits Update: Rottenstein Law Group Responds to Femur Fracture Verdict in Merck’s Favor
7. Fosamax Lawsuits Update: Rottenstein Law Group LLP Responds to Fosamax Cystic Fibrosis Study
8. Warning Labels Update Survives Dismissal in Fosamax Multidistrict Litigation: Now, AttorneyOne Can Provide Advice
9. More than 2,900 Fosamax Lawsuit Claims Now Pending in Multicounty New Jersey Litigation, Proceeding Continues to Move Forward, Bernstein Liebhard LLP Reports
10. LawyersandSettlements.com Issues Report on Prostate Health Claim Lawsuits and Propecia Side Effect Litigation
11. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... MD (PRWEB) , ... June 24, 2016 , ... ... protocols for human induced pluripotent stem (iPS) cells and other difficult to transfect ... G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 ... today announced the appointment of Dr. Edward ... as a Non-Executive Director, effective June 23, 2016.Dr. ... Compensation and Nominations and Governance Committees.  As a ... will provide independent expertise and strategic counsel to ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology: